Evidence map›Paper›PMID 30190268›Full record

ArticleThe European respiratory journal2018

SPLUNC1 degradation by the cystic fibrosis mucosal environment drives airway surface liquid dehydration.

Megan J Webster, Boris Reidel, Chong D Tan, Arunava Ghosh, Neil E Alexis, Scott H Donaldson, Mehmet Kesimer, Carla M P Ribeiro, Robert Tarran

Open access · bronzeAbstract read
In one paragraph

Article in The European respiratory journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Neutrophil store-operated CaJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Vaping-Induced Proteolysis Causes Airway Surface Dehydration.International journal of molecular sciences · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. SPLUNC1: a novel marker of cystic fibrosis exacerbations.The European respiratory journal · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Mucus, mucins, and cystic fibrosis.Pediatric pulmonology · 2019
    Review
  17. SPLUNC1 Loses Its Antimicrobial Activity in Acidic Cystic Fibrosis Airway Secretions.American journal of respiratory and critical care medicine · 2019
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Megan J WebsterMarsico Lung Institute, The University of North Carolina, Chapel Hill, NC, USA.
Boris ReidelMarsico Lung Institute, The University of North Carolina, Chapel Hill, NC, USA.
Chong D TanMarsico Lung Institute, The University of North Carolina, Chapel Hill, NC, USA.
Arunava GhoshMarsico Lung Institute, The University of North Carolina, Chapel Hill, NC, USA.
Neil E AlexisCenter for Asthma and Lung Biology, The University of North Carolina, Chapel Hill, NC, USA.
Scott H DonaldsonMarsico Lung Institute, The University of North Carolina, Chapel Hill, NC, USA.
Mehmet KesimerMarsico Lung Institute, The University of North Carolina, Chapel Hill, NC, USA.
Carla M P RibeiroMarsico Lung Institute, The University of North Carolina, Chapel Hill, NC, USA.
Robert TarranMarsico Lung Institute, The University of North Carolina, Chapel Hill, NC, USA robert_tarran@med.unc.edu.
Lung Institute · USUniversity of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
Vector CoreP30DK065988 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Martina Gentzsch · 2004 to 2026
$26.5M
SPLUNC1-Derived Peptides as ENaC AntagonistsR01HL108927 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TARRAN, ROBERT · 2012 to 2015
$1.4M
NCI NIH HHS P30 CA016086NHLBI NIH HHS R01 HL108927NIDDK NIH HHS P30 DK065988
6 · The paper itself

Abstract

The multi-organ disease cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane regulator gene (

Indexed as

Cells, CulturedCystic FibrosisDehydrationEpithelial CellsEpithelial Sodium ChannelsGlycoproteinsHumansIon TransportLungPhosphoproteinsRespiratory MucosaBPIFA1 protein, humanEpithelial Sodium ChannelsGlycoproteinsPhosphoproteins

Identifiers

PMID30190268
PMCPMC6547379
OpenAlexW2890207287

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.